EU warehouse review
Available
Retatrutide 5 mg — Research use only
Lyophilized Retatrutide peptide supplied for laboratory research use only.
€45.00 per vial€45.00
Research material only. Not for human or veterinary use. No instructions for administration, dosing, or therapeutic use are provided.
CAS2381089-83-2
Variant5 mg
Current-lot recordsRequest availability
FormLyophilized powder
StorageFollow lot-specific label and documentation
AvailabilityAvailable
COA on requestCurrent lot documentation is confirmed during order review.
Tracked EU shippingShipping cost and destination eligibility are reviewed before payment.
Payment after reviewPayment instructions are sent only after availability is confirmed.
Next working day dispatchOrders are prepared for the next working day after payment is received.
Triple agonist profile
Retatrutide research context
Retatrutide is reviewed as a GIP, GLP-1 and glucagon receptor agonist research tool. It is most useful when the question involves multi-receptor metabolic signalling rather than simple GLP-1 comparison.
What makes retatrutide different from tirzepatide?
Tirzepatide is a GIP/GLP-1 dual agonist. Retatrutide adds glucagon receptor agonism, so the research question changes.
Which guide should I read first?
Start with the retatrutide triple-agonist guide, then compare it with tirzepatide or semaglutide depending on the study context.
Related reading
Useful guides before ordering Retatrutide
Internal guide links help customers compare options, understand documentation and avoid relying on a single catalog page.
Product specifications
| CAS number | 2381089-83-2 |
|---|---|
| Current-lot documentation | Request availability before ordering |
| Form | Lyophilized powder |
| Storage | Follow lot-specific label and documentation |
Related catalog
You may also need